MINI FUTURE LONG - VIRBAC Share Price

Certificat

HS3IB

FRBNPP04UNB2

Market Closed - Euronext Paris 10:00:01 10/05/2024 pm IST
1.43 EUR 0.00% Intraday chart for MINI FUTURE LONG - VIRBAC
Current month+6.72%
1 month+2.14%
Date Price Change Volume
10/24/10 1.43 0.00% 11
09/24/09 1.43 0.00% 13
08/24/08 1.43 +5.93% 23
07/24/07 1.35 -4.26% 19
06/24/06 1.41 -0.70% 21

Real-time Euronext Paris

Last update May 10, 2024 at 10:00 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying VIRBAC
IssuerLogo Issuer BNP Paribas BNP Paribas
HS3IB
ISINFRBNPP04UNB2
Date issued 27/09/2022
Strike 217.1
Maturity Unlimited
Parity 100 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.635
Lowest since issue 0.255

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
357 EUR
Average target price
368 EUR
Spread / Average Target
+3.08%
Consensus
  1. Stock Market
  2. Certificates
  3. HS3IB Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW